SYNTAX II Trial: 5yr Data Shows Reduction in MACE in PCI | Prof Adrian Banning
SYNTAX II Trial: Role of Assessment in Multivessel Disease
SYNTAX II Trial: Complex PCI Case in a High-Risk Patient
SYNTAX Scores
SYNTAX trial influence in the USA
Heart Minute | Clinical Syntax Score Predicts Outcome After DES
CABG Still Winner in SYNTAX
SYNTAX II: IVUS Imaging in PCI
Lessons learned from the 2-year results of SYNTAX II
SYNTAX Trial: PCI vs. CABG - A Head-to-Head Comparison/syntax trial cardiology/syntax score/Syntax
Effect of SYNTAX trial in Europe
Daniel Thuijs, ESC 2019 - the SYNTAX Trial
SYNTAX 2020 score for daily clinical use - EuroPCR 2021
SYNTAX Trial: PCI vs. CABG - Insights into Long-Term Outcomes/syntax score/syntax trial/SYNTAX
10-year Syntaxes bifurcation - Prof Patrick SERRUYS
SYNTAX II Trial: Rotational Atherectomy vs Cutting & Scoring Balloons
Dr. Fearon "PCI or CABG for Multivessel CAD Results of the FAME 3 Trial and more..."
Two year results of the SYNTAX study
Modern PCI Patient Care: 5-Year SYNTAX II Results
ESC 2019: The SYNTAX Extended Survival Study - Dr Daniel JFM Thujis
